Volume 67 Received 18 August 2011 | ||||||||||
| ||||||||||
-chlorido-bis[diacetonitrilechloridooxidovanadium(IV)]aDepartment of Chemistry, Faculty of Technology, Tomas Bata University in Zlin, Nam. T. G. Masaryka 275 Zlin, 762 72, Czech Republic, and bDepartment of Chemistry, Faculty of Science, Masaryk University, Kamenice 5 Brno-Bohunice, 625 00, Czech Republic
Correspondence e-mail: dastych@gmail.com
The title compound, [V2Cl4O2(CH3CN)4], is a centrosymmetric dinuclear VIV complex associated with four molecules of acetonitrile. The coordination around both VIV atoms is essentially square-planar, involving three Cl atoms and one O atom [maximum deviation = 0.017 (3) Å for the O atom]. The augmented octahedral coordination of the metal atom is completed by the N atoms of acetonitrile ligands. The VIV atoms are linked by two Cl atoms, acting as bridging atoms. The crystal studied was a non-merohedral twin with a ratio of the two twin components of 0.8200 (3):0.1800 (3). Although Cl and O atoms are present as potential acceptors in the title compound, no hydrogen bonds were observed in the crystal structure.
For the biological activity of vanadium(IV) compounds, see: D'Cruz et al. (2003
); Lopez et al. (1976
); Lu et al. (2001
); Shi et al. (1996
). For Ziegler-Natta catalysts, see: Hagen et al. (2002
). For the synthesis of chloridooxidovanadium(IV) complexes, see: du Preez & Sadle (1967
); Homden et al. (2009
); Kern (1962
); Papoutsakis et al. (2004
); Priebsch & Rehder (1990
).
|
Data collection: CrysAlis CCD (Oxford Diffraction, 2009
); cell refinement: CrysAlis RED (Oxford Diffraction, 2009
); data reduction: CrysAlis RED; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
) and PLATON (Spek, 2009
); molecular graphics: Mercury (Macrae et al., 2008
); software used to prepare material for publication: SHELXL97.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: RU2013 ).
D'Cruz, O. J., Dong, Y. H. & Uckun, F. M. (2003). Biochem. Biophys. Res. Commun. 302, 253-264. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Hagen, H., Boersma, J. & van Koten, G. (2002). Chem. Soc. Rev. 31, 357-364.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Homden, D., Redshaw, C., Warford, L., Hughes, D. L., Wright, J. A., Dale, S. H. & Elsegood, M. R. J. (2009). Dalton Trans. pp. 8900-8910.
![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Kern, R. J. (1962). J. Inorg. Nucl. Chem. 24, 1105-1109.
![[ISI]](../../../../../../logos/isiborder.gif)
Lopez, V., Stevens, T. & Lindquist, R. N. (1976). Arch. Biochem. Biophys. 175, 31-38. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Lu, B., Enni, D., Lai, R., Bogdanovic, E., Nikolov, R., Salamon, L., Fantus, C., Le-Tien, H. & Fantus, I. G. (2001). J. Biol. Chem. 276, 35589-35598.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466-470.
![[details]](../../../../../../j/graphics/details.gif)
Oxford Diffraction (2009). CrysAlis RED and CrysAlis CCD. Oxford Diffraction Ltd, Yarnton, England.
Papoutsakis, D., Ichimura, A. S., Young, V. G., Jackson, J. E. & Nocera, D. G. (2004). Dalton Trans. pp. 224-228.
![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Preez, J. G. H. du & Sadle, F. G. (1967). Inorg. Chim. Acta, 1, 202-204.
Priebsch, W. & Rehder, D. (1990). Inorg. Chem. 29, 3013-3019.
![[ISI]](../../../../../../logos/isiborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Shi, X., Wang, P., Jiang, H., Mao, Y., Ahmed, N. & Dalal, N. (1996). Ann. Clin. Lab. Sci. 26, 39-49. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)